IGBP1P4

Across TCGA pan-cancer cohorts, IGBP1P4 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of IGBP1P4’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where IGBP1P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types IGBP1P4 is over-expressed in tumor, although a few such as KIRP and KIRC show the opposite, repressed pattern.

LUAD, KIRP, and COAD are the cancer types where IGBP1P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in IGBP1P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	II,III,IV	+0.819	<.001	8	view →
KIRP	All	III,IV	−0.063	.002	6	view →
COAD	All	All	+0.098	.003	5	view →
LIHC	All	All	+0.029	.025	3	view →
KIRC	All	II,III,IV	−0.044	.019	2	view →
THCA	Female	All	−0.142	.008	1	view →
KICH	All	All	−0.065	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

IGBP1P4–LUAD

Open the LUAD breakdown →